Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Mallinckrodt
Express Scripts
Colorcon
Moodys

Last Updated: May 27, 2022

CLINICAL TRIALS PROFILE FOR ROPIVACAINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Ropivacaine Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00130091 ↗ The Addition of Clonidine to 0.2% Ropivacaine for Wound Instillation After Minor Lower Abdominal Surgery in Children Completed Children's Hospital of Eastern Ontario Phase 2 2009-09-01 The current study will compare the effects on postoperative pain relief of "freezing" (ropivacaine 0.2 %) alone and in combination with clonidine for a nerve block in children undergoing hernia repair. The researchers anticipate that the addition of clonidine to "freezing" will result in prolongation of postoperative pain relief in children undergoing hernia repair compared to "freezing" used alone.
NCT00150865 ↗ Evaluation of Efficacy of Lumbar Plexus Bloc After Hip Surgery Completed University Hospital, Angers N/A 2001-09-01 Compare lumbar plexus block with ropivacaine 0.475%, 0.4 ml/kg to saline. Each group randomized, includes 30 patients. block performed preoperatively Surgery under general anesthesia. Postoperative evaluation of pain (VAS) as first endpoint, and also morphine consumption via PCA device. Follow-up : 24h. Expectation : sizeable reduction of pain with block, of duration.
NCT00197340 ↗ Antepartum Chronic Epidural Therapy (ACET) to Improve Blood Flow to the Uterus, Placenta and Baby in Pre-Eclampsia and Intrauterine Growth Restriction Completed International Anesthesia Research Society (IARS) Phase 3 2003-08-01 Pre-eclampsia (PE) and intrauterine growth restriction (IUGR) are common and important disorders of pregnancy. Both disorders are associated with an impairment of uteroplacental blood flow (UPBF). No effective therapy has been identified to reliably improve UPBF in these patients and typically, obstetric management involves interventional delivery, particularly problematic when remote from term. This study assess the hypothesis that epidural local anesthetics may improve UPBF in these patients.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Ropivacaine Hydrochloride

Condition Name

Condition Name for Ropivacaine Hydrochloride
Intervention Trials
Pain, Postoperative 100
Postoperative Pain 82
Pain 68
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Ropivacaine Hydrochloride
Intervention Trials
Pain, Postoperative 228
Fractures, Bone 36
Osteoarthritis 33
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Ropivacaine Hydrochloride

Trials by Country

Trials by Country for Ropivacaine Hydrochloride
Location Trials
United States 233
France 77
China 56
Denmark 53
Canada 46
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Ropivacaine Hydrochloride
Location Trials
California 35
Ohio 24
Pennsylvania 23
Texas 17
North Carolina 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Ropivacaine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Ropivacaine Hydrochloride
Clinical Trial Phase Trials
Phase 4 324
Phase 3 99
Phase 2/Phase 3 18
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Ropivacaine Hydrochloride
Clinical Trial Phase Trials
Completed 397
Unknown status 110
Recruiting 99
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Ropivacaine Hydrochloride

Sponsor Name

Sponsor Name for Ropivacaine Hydrochloride
Sponsor Trials
University of California, San Diego 18
Zealand University Hospital 13
Duke University 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Ropivacaine Hydrochloride
Sponsor Trials
Other 973
Industry 36
U.S. Fed 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Moodys
Baxter
Dow
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.